METHOD FOR PREPARING HIGH-THROUGHPUT SEQUENCING LIBRARY BASED ON NESTED MUTIPLEX PCR AND KIT FOR THE SAME

Abstract

A method and kit for preparing a high-throughput sequencing library based on nested multiplex PCR are provided. The method includes: amplifying a targeted region using a forward primer and a reverse primer, where the reverse primer includes a reverse specific sequence at a 3′-end and a first universal sequencing sequence at a 5′-end; purifying; and amplifying the purified product using a nested primer located downstream of the forward primer, a first tag primer, and a second universal primer, where the nested primer includes a second universal sequencing sequence at a 5′-end and a specific sequence at a 3′-end, a 3′-end sequence of the first tag primer is partially or completely the same as the first universal sequencing sequence, the first tag primer further includes a first tag sequence, and a 3′-end sequence of the second universal primer is partially or completely the same as the second universal sequencing sequence.

Claims

1. A method for preparing a high-throughput sequencing library based on nested multiplex PCR, the method comprising: a first round of PCR amplification: amplifying a targeted region by using a forward primer and a reverse primer, wherein the forward primer is a forward specific sequence binding to the targeted region, and the reverse primer comprises a reverse specific sequence binding to the targeted region at a 3′-end and a first universal sequencing sequence at a 5′-end; purification of amplification product: purifying a product of the first round of PCR amplification; and a second round of PCR amplification: amplifying the purified product by using a nested primer, a first tag primer, and a second universal primer, wherein the nested primer is located downstream of the forward primer, the nested primer comprises a second universal sequencing sequence at a 5′-end and a specific sequence at a 3′-end, a 3′-end sequence of the first tag primer is partially or completely the same as the first universal sequencing sequence of the reverse primer at the 5′-end, the first tag primer further comprises a first tag sequence, and a 3′-end sequence of the second universal primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end.

2. The method according to claim 1, wherein the second universal primer is a second tag primer, a 3′-end sequence of the second tag primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end, and the second tag primer comprises a second tag sequence.

3. A method for preparing a high-throughput sequencing library based on nested multiplex PCR, the method comprising: a first round of PCR amplification: amplifying a targeted region by using a forward primer, a reverse primer, and a first tag primer, wherein the forward primer is a forward specific sequence binding to the targeted region, the reverse primer comprises a reverse specific sequence binding to the targeted region at a 3′-end and a first universal sequencing sequence at a 5′-end, a 3′-end sequence of the first tag primer is partially or completely the same as the first universal sequence of the reverse primer at the 5′-end, and the first tag primer further comprises a first tag sequence; purification of amplification product: purifying a product of the first round of PCR amplification; and a second round of PCR amplification: amplifying the purified product by using a nested primer, a first universal primer, and a second universal primer, wherein the nested primer is located downstream of the forward primer, the nested primer comprises a second universal sequencing sequence at a 5′-end and a specific sequence at a 3′-end, a 3′-end sequence of the first universal primer is partially or completely the same as a 5′-end sequence of the first tag primer, and a 3′-end sequence of the second universal primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end.

4. The method according to claim 3, wherein the second universal primer is a second tag primer, a 3′-end sequence of the second tag primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end, and the second tag primer comprises a second tag sequence.

5. The method according to claim 1, wherein the reverse primer further comprises a molecular tag sequence.

6. The method according to claim 5, wherein the molecular tag sequence is a random sequence of 8 bp to 24 bp.

7. The method according to claim 1, wherein a plurality of continuous targeted regions is amplified, and each of the plurality of continuous targeted regions has the corresponding forward primer, reverse primer, and nested primer, and adjacent amplicon regions have an amplification overlap.

8. The method according to claim 7, wherein the forward primer, the reverse primer, and the nested primer are a primer pool composed of a plurality of primers respectively targeting different targeted regions of the plurality of continuous targeted regions.

9. The method according to claim 7, wherein the forward primer of each targeted region and the forward primer of an adjacent targeted region are in opposite amplification directions; the nested primer of each targeted region and the nested primer of an adjacent targeted region are in opposite amplification directions; and the reverse primer of each targeted region and the reverse primer of an adjacent targeted region are in opposite amplification directions.

10. The method according to claim 1, wherein the first round of PCR amplification and/or the second round of PCR amplification are each performed for 2 to 30 cycles.

11. The method according to claim 1, wherein the first tag sequence and/or the second tag sequence each have a length of 8 bp to 15 bp.

12. A kit for preparing a high-throughput sequencing library based on nested multiplex PCR, the kit comprising: a first round of PCR amplification primers, comprising a forward primer and a reverse primer, wherein the forward primer is a forward specific sequence binding to a targeted region, the reverse primer comprises a reverse specific sequence binding to the targeted region at a 3′-end and a first universal sequencing sequence at a 5′-end, the first round of PCR amplification primers are used to perform a first round of PCR amplification on the targeted region; and a second round of PCR amplification primers, comprising a nested primer, a first tag primer, and a second universal primer, wherein the nested primer is located downstream of the forward primer, the nested primer comprises a second universal sequencing sequence at a 5′-end and a specific sequence at a 3′-end, a 3′-end sequence of the first tag primer is partially or completely the same as the first universal sequencing sequence of the reverse primer at the 5′-end, the first tag sequence further comprises a first tag sequence, a 3′-end sequence of the second universal primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end, and the second round of PCR amplification primers are used to perform a second round of PCR amplification on a purified product of the first round of PCR amplification, or the kit comprising: a first round of PCR amplification primers, comprising a forward primer, a reverse primer, and a first tag primer, wherein the forward primer is a forward specific sequence binding to a targeted region, the reverse primer comprises a reverse specific sequence binding to the targeted region at a 3′-end and a first universal sequencing sequence at a 5′-end, a 3′-end sequence of the first tag primer is partially or completely the same as the first universal sequencing sequence of the reverse primer at the 5′-end, the first tag primer further comprises a first tag sequence, and the first round of PCR amplification primers are used to perform a first round of PCR amplification on the targeted region; and a second round of PCR amplification primers, comprising a nested primer, a first universal primer, and a second universal primer, wherein the nested primer is located downstream of the forward primer, the nested primer comprises a second universal sequencing sequence at a 5′-end and a specific sequence at a 3′-end, a 3′-end sequence of the first universal primer is partially or completely the same as a 5′-end sequence of the first tag primer, a 3′-end sequence of the second universal primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end, and the second round of PCR amplification primers are used to perform a second round of PCR amplification on a purified product of the first round of PCR amplification.

13. The kit according to claim 12, wherein the second universal primer is a second tag primer, a 3′-end sequence of the second tag primer is partially or completely the same as the second universal sequencing sequence of the nested primer at the 5′-end, and the second tag primer comprises a second tag sequence.

14.-15. (canceled)

16. The kit according to claim 12, wherein the reverse primer further comprises a molecular tag sequence.

17. The kit according to claim 16, wherein the molecular tag sequence is a random sequence of 8 bp to 24 bp.

18. The kit according to claim 12, wherein the forward primer, the reverse primer, and the nested primer are a primer pool composed of a plurality of primers respectively targeting a plurality of continuous targeted region, and adjacent amplicon regions have an amplification overlap.

19. The kit according to claim 18, wherein the forward primer of each targeted region and the forward primer of an adjacent targeted region are in opposite amplification directions; the nested primer of each targeted region and the nested primer of an adjacent targeted region are in opposite amplification directions; and the reverse primer of each targeted region and the reverse primer of an adjacent targeted region are in opposite amplification directions.

20. The kit according to claim 12, wherein the first tag sequence and/or the second tag sequence each have a length of 8 bp to 15 bp.

Description

BRIEF DESCRIPTION OF DRAWINGS

[0029] FIG. 1 is a schematic flowchart of a two-step PCR amplification process known in the prior art;

[0030] FIG. 2 is a schematic flowchart of a nested multiplex PCR amplification process in an embodiment of the present disclosure;

[0031] FIG. 3 is a schematic diagram of a nested multiplex PCR amplification of continuous regions in an embodiment of the present disclosure;

[0032] FIG. 4 illustrates (a) a schematic diagram of a conventional nested PCR primer design in an embodiment of the present disclosure; (b) a schematic diagram of a nested PCR primer design introduced with molecular tags (b), and (c) a schematic diagram of a nested PCR primer design for continuous regions;

[0033] FIG. 5 is a schematic diagram illustrating different manners for introducing sample tag in an embodiment of the present disclosure;

[0034] FIG. 6 is a schematic diagram illustrating different manners for introducing sample tag in an embodiment of the present disclosure;

[0035] FIG. 7 is a diagram illustrating results of uniformity experiments of different amplicons in an embodiment of the present disclosure; and

[0036] FIG. 8 is an electrophoresis diagram of a library obtained by a nested multiplex PCR in an embodiment of the present disclosure.

DESCRIPTION OF EMBODIMENTS

[0037] The present disclosure will be further described in detail below through specific embodiments in conjunction with the accompanying drawings. In the following embodiments, many detailed descriptions are used to facilitate the understanding of the present disclosure. However, those skilled in the art could understand that some of the features can be omitted under different circumstances, or can be replaced by other materials and methods.

[0038] In addition, the features, operations, or features described in the description can be combined in any appropriate manner to form various implementations. Also, the order of the steps or actions in the method description can also be exchanged or adjusted in a manner that is apparent to those skilled in the art. Therefore, the various sequences in the description and the drawings are only for the purpose of clearly describing a certain embodiment, but are not intended to be a necessary sequence, unless it is otherwise specified that a certain sequence must be followed.

[0039] The serial numbers assigned to the features herein, such as “first”, “second”, etc., are only used to distinguish the described objects and do not have any sequence or technical meaning.

[0040] FIG. 1 illustrates a two-step PCR amplification process in the prior art. In the process of specific amplification, two specific primers (i.e., specific primer 1 and specific primer 2 in FIG. 1) carry partial sequences of two sequencing adapters, respectively. These two primers form primer dimers during a first round of PCR amplification. This primer dimers will be amplified in a second round of PCR universal amplification, thereby obtaining a large amount of dimer products, which will affect the sequencing data.

[0041] The method of the present disclosure solves the problem that the primer dimer products formed during the specific PCR amplification process are amplified in the subsequent universal PCR amplification process.

[0042] In the method of the present disclosure as illustrated in FIG. 2, during the specific amplification, one specific primer (hereinafter referred to as reverse primer) carries a first universal sequencing sequence, and another specific primer (hereinafter referred to as forward primer) does not carry a sequencing sequence. Two reverse primers form a primer dimer (primer dimer 3 in FIG. 2), and due to the presence of universal sequencing sequences, these primers will form a stem-loop structure during subsequent amplification and will not be amplified. A primer dimer formed by two forward primers (primer dimer 1 in FIG. 2), and a primer dimer formed by the forward primer and the reverse primer (primer dimer 2 in FIG. 2) cannot be used by subsequent universal primers and thus cannot be amplified. In this way, a proportion of primer dimers in the final product of the first round of PCR amplification can be effectively reduced.

[0043] As illustrated in FIG. 2, through a semi-nested amplification, the specificity of amplification of the targeted region can be improved. Specifically, in a second round of PCR amplification, a nested primer, which is designed downstream of the forward primer, carries a second universal sequencing sequence. The nested primer and a first tag primer are used to perform the second round of PCR amplification on the obtained product, so as to obtain the final sequencing library. By employing the nested amplification, this method performs a further step of specific selection on the basis of the product of the first round of PCR amplification, thereby increasing the specificity of the final product. This step includes adding the nested primers and the second universal primers for the PCR amplification. During the amplification, only the nested primers may form primer dimers (primer dimer 4 in FIG. 2), and the primer dimers formed by the nested primers will form stem-loop loop structures in the subsequent amplification and will not be amplified, thereby also significantly inhibiting the formation of primer dimers.

[0044] As illustrated in FIG. 3 and FIG. 4, a special primer amplification strategy is used for continuous regions, to avoid mutual amplification of overlapping primers between overlapping amplicons. Specifically, each region includes three primers, i.e., the forward primer, the nested primer, and the reverse primer. It is designed that each forward primer and a next forward primer adjacent thereto can form an amplification overlap, each nested primer and a next nested primers adjacent thereto can form an amplification overlap, and each reverse primer and a next reverse primer can form an amplification overlap (FIG. 4). The forward primers can form a product with each other (product 4 in FIG. 3), which can be used for amplification by the nested primer in the second step of nested amplification. However, because the nested primers each carry the second universal sequencing sequence, the amplification of the product 4 can be inhibited by forming a stem-loop structure during the subsequent amplification. The reverse primers may form a product with each other (product 2 in FIG. 3). Since the reverse primers each carry the first universal sequencing sequence, the amplification of the product 2 can be inhibited by forming a stem-loop structure in the subsequent amplification (FIG. 3). Therefore, none of these overlapping products will not be amplified.

[0045] As illustrated in FIG. 4a, for each amplicon, three primers are designed: forward primer, nested primer, and reverse primer, in order to perform the two-step PCR amplification. The nested primer is located downstream of the forward primer, and the nested primer and the forward primer may be overlapped each other or spaced apart from each other. The 5′-end of the nested primer has a universal sequencing sequence segment, the 3′-end of the nested primer is a specific sequence, and the 3′-end sequence is designed to locate upstream of the targeted region to be amplified. The forward primer is designed to locate upstream of the nested primer, the 5′-end of the forward primer can be added with a universal sequencing sequence or not (preferably not). The 5′-end of the reverse primer has a universal sequencing sequence, the 3′-end of the reverse primer is a specific sequence, and the 3′-end sequence is designed to locate downstream of the targeted region to be amplified.

[0046] As illustrated in FIG. 4b, if a low-frequency mutation is to be detected, a molecular tag sequence is required to be added between the universal sequence and specific sequence of the reverse primer. The molecular tag can be a random sequence of 8 bp to 24 bp, and thus there may be 4.sup.8-24 kinds of random molecular tags available for labeling the original DNA molecules. When the number of molecular tags is much greater than the number of templates, each template carries a unique molecular tag, through which a source the original DNA template can be traced to remove the amplified duplications and sequencing errors. The introduction of molecular tags to primers will dramatically increase the possibility of dimer formation between the primers, but the primer dimers formed by the present method will be effectively inhibited in the subsequent process.

[0047] As illustrated in FIG. 4c, for the amplification of continuous regions, multiple pairs of primers are designed to cover the continuous regions, and adjacent amplicon having an overlapping region, that is, except for the primer sequences in the amplicons, the 3′-end of each amplification is located downstream of the 5′-end of a next amplicon. Each region is amplified with three primers, i.e., the forward primer, the nested primer, and the reverse primer. The forward primer, nested primer, and reverse primer of each targeted region are designed in opposite directions to the forward primer, nested primer, and reverse primer of an adjacent targeted region, respectively, i.e., amplification directions are opposite. For example, a forward primer 1, a nested primer 1, and a reverse primer 1 are arranged sequentially from 5′-end to 3′-end of a first amplicon; then a reverse primer 2, a nested primer 2, and a forward primer 2 are arranged sequentially from 5′-end to 3′-end of a second amplicon; a forward primer 3, a nested primer 3, and a reverse primer 3 are arranged sequentially from 5′-end to 3′-end of a third amplicon, etc., until all amplicons can cover the entire continuous regions. The 3′-end of the reverse primer 2 of the second amplicon is located upstream of the 3′-end of the reverse primer 1, and the 3′-end of the nested primer 3 of the third amplicon is located upstream of the 3′-end of the nested primer 2. With such design, all the sequences in the continuous regions can be amplified into the corresponding amplicons.

[0048] As illustrated in FIG. 5a, in the first round of PCR amplification, 2-30 rounds of PCR amplification are performed using the forward primers and the reverse primers. The obtained product is purified, excess primers and other ions are removed, and then the second round of PCR amplification is performed. In the second round of PCR amplification, 2 to 30 cycles of amplification are performed using the nested primers, the first tag primer, and the second universal primers. Wherein the 3′-end sequence of the first tag primer and the 5′ end of the reverse primer are either partially or completely the same in sequence. Each tag primer include a tag sequence of 8 bp to 15 bp in the middle, and the tag sequence can have different sequences on different sequencing platforms, in order to distinguish different samples for subsequent mixed sequencing of multiple samples. The 3′-end sequence of the second universal primer and the 5′-end sequence of the nested primer are either partially or completely the same. In the first cycle of amplification, the amplification is performed using the nested primers and the first tag primer. In the subsequent cycles, the nested primers, the first tag primer and the second universal primers together are used to amplify the target library, so as to finally obtain an amplicon library.

[0049] As illustrated in FIG. 5b, for dual-sample tag sequence sequencing, in the second round of PCR amplification, 2 to 30 cycles of amplification are performed using the nested primers, the first tag primer, and the second tag primer. The 3′-end sequence of the first tag sequence is partially or completely the same as the 5′-end sequence of the reverse primer. The 3′-end sequence of the second tag primer is partially or completely the same as the 5′-end sequence of the nested primer. Each tag primer includes a tag sequence of 8bp to 15bp in the middle. The tag sequence can have different sequences on different sequencing platforms, in order to distinguish different samples for the subsequent mixed sequencing of multiple samples. In the first cycle of amplification, the amplification is performed with the nested primers and the first tag primer. In the subsequent cycles, the nested primers, the first tag primer, and the second tag primer together are used to amplify the target library, so as to finally obtain an amplicon library of double sample tags.

[0050] As illustrated in FIG. 6a, for the first round of PCR amplification, in addition to the forward primers and the reverse primers, the first tag primer can also be added. The first tag primer has a tag sequence of 8 nt to 15 nt in the middle. In this way, the samples can be distinguished in the first round of PCR amplification, and distinguishing the different samples is conducive to the subsequent mixed sequencing of multiple samples. The 3′-end of the first tag primer partially or completely overlaps the 5′-end of the reverse primer. In the first cycle of amplification, the amplification is performed with the forward primers and the reverse primers, and in the subsequent cycles, the amplification is performed with the forward primers, the reverse primers, and the first tag primer. In the second round of PCR amplification, the nested primers, the first universal primers, and the second universal primers are used for 2 to 30 cycles of amplification. The 3′-end of the first universal primer is either partially or completely the same as the 5′-end of the first tag primer. In the first cycle of amplification, the amplification is performed with the first universal primers and the nested primers, and in the subsequent cycles, the amplification is performed with the first universal primers, the second universal primers, and the nested primers together, so as to obtain a sequencing library.

[0051] As illustrated in FIG. 6b, for dual-sample tag sequence sequencing, 2 to 30 cycles of amplification is performed with the nested primers, the second tag primer, and the first universal primers in the second round of PCR amplification. The 3′-end of the second tag is partially or completely the same as the 5′-end of the nested primer. The tag primer has a tag sequence of 8 bp to 15 bp in the middle, and the tag sequence has different sequences on different sequencing platforms, in order to distinguish different samples for facilitating the subsequent multi-sample mixed sequencing. The 3′-end sequence of the first universal primer is partially or completely the same as the 5′-end sequence of the first tag primer. In the first cycle of amplification, the amplification is performed with the nested primers and the first universal primers. In the subsequent cycles, the nested primers, the second tag primer, and the first universal primers together are used to amplify the target library to finally obtain an amplicon library of double sample tags.

[0052] The technical solutions of the present disclosure are described in detail below by means of specific examples. It should be understood that the examples are only illustrative and should not be construed as limiting the protection scope of the present disclosure.

EXAMPLE 1

[0053] Primer design: primers of nested multiplex PCR were designed for tumor drug-related sites. Each amplicon consisted of a forward primer, a nested primer, and a reverse primer. A random sequence of 15nt was introduced into the reverse primer for tracing a source of the template and error correction. These primers were used to prepare a multiplex PCR library of a standard HD701 (Horizon) and complete high-throughput sequencing. The obtained data was analyzed and then the mutation at each targeted site was detected.

[0054] 1. In a first round of PCR amplification, QIAGEN Multiplex PCR Kit (Cat No./ID: 206143) was used for PCR amplification.

[0055] A reagent system listed in Table 1 below was formulated in a 200 μL PCR tube:

TABLE-US-00001 TABLE 1 Components Amount Product of previous step (Standard HD701)  20 μL 2X PCR reaction enzyme  25 μL Forward primer pool (10 μM) 2.5 μL Reverse primer pool (10 μM) 2.5 μL Total  50 μL #The forward primer pool and the reverse primer pool are listed in Table 2 and Table 3.

TABLE-US-00002 TABLE 2 Forward primer pool Primer Sequence Forward primer 01 AATGACATAACAGTTATGATTTTGCAG (SEQ ID NO: 1) Forward primer 02 TGAGTCCTGGCGCTGTGT (SEQ ID NO: 2) Forward primer 03 TGTTGGATCATATTCGTCCACAA (SEQ ID NO: 3) Forward primer 04 CCAGCAGGATGAACCGGG (SEQ ID NO: 4) Forward primer 05 AGTGGAGAAGCTCCCAACC (SEQ ID NO: 5) Forward primer 06 GACAACCCCCACGTGTGC (SEQ ID NO: 6) Forward primer 07 GCAGCCAGGAACGTACTG (SEQ ID NO: 7) Forward primer 08 CCTTACTCATGGTCGGATCACA (SEQ ID NO: 8) Forward primer 09 AGGGACTAGGCGTGGGAT (SEQ ID NO: 9) Forward primer 10 GACAAACTCTACGTCTCCTCC (SEQ ID NO: 10) Forward primer 11 GCCTCAATTCTTACCATCCACAA (SEQ ID NO: 11) Forward primer 12 GAGACAATGAATTAAGGGAAAATGACAAAG (SEQ ID NO: 12) Forward primer 13 CATTCGAAAGACYCTAGCCTTAGATA (SEQ ID NO: 13)

[0056] The forward primer pool was formed by mixing 10 μM of the above primers at an equimolar ratio, and Y was a degenerate base.

TABLE-US-00003 TABLE 3 Reverse primer pool Primer Sequence Reverse primer 01 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NAGGACTTAGCAAGAAGTTATGGAA (SEQ ID NO: 27) Reverse primer 02 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NCATGATGGATGTCACGTTCTCAAA (SEQ ID NO: 27) Reverse primer 03 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NGAATATAAACTTGTGGTAGTTGGAGCT (SEQ ID NO: 29) Reverse primer 04 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NTGGTTACATCCCTCTCTGCT (SEQ ID NO: 30) Reverse primer 05 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NTTATACACCGTGCCGAACGC (SEQ ID NO: 31) Reverse primer 06 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NTGTTCCCGGACATAGTCCAG (SEQ ID NO: 32) Reverse primer 07 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NGCCTCCTTCTGCATGGTATTCTTT (SEQ ID NO: 33) Reverse primer 08 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NGAGAATGGGTACTCACGTTTCCTT (SEQ ID NO: 34) Reverse primer 09 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NTGTGGAAAAGTCCCAATGGAACTATC (SEQ ID NO: 35) Reverse primer 10 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NCTCTCTCCACCAGAGCGA (SEQ ID NO: 36) Reverse primer 11 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NAATAGGTGATTTTGGTCTAGCTACA (SEQ ID NO: 37) Reverse primer 12 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NATTTTAGCACTTACCTGTGACTCCA (SEQ ID NO: 38) Reverse primer 13 CGCTTGGCCTCCGACTTNNNNNNNNNNNNNN NTGTGTGGAAGATCCAATCCATT (SEQ ID NO: 39)

[0057] The reverse primer pool was formed by mixing 10 μM of the above primers at an equimolar ratio.

[0058] The first round of PCR amplification was performed according to the procedure as listed in Table 4 below:

TABLE-US-00004 TABLE 4 Temperature Duration The number of cycles 95° C. 2 min 1 cycle  95° C. 10 s 2 cycles 62° C. 2 min 72° C. 30 s 72° C. 5 min 1 cycle 

[0059] 80 μL of XP magnetic beads were added to the obtained PCR product for purification (Agencourt AMPure XP magnetic beads from Beckman, Cat No: A63881), and the obtained product was dissolved in 20 μL of TE solution.

[0060] 2. For the second round of PCR amplification, QIAGEN Multiplex PCR Kit (Cat No./ID: 206143) was used for PCR amplification.

[0061] A reagent system as listed in Table 5 was prepared in a 200 μL PCR tube:

TABLE-US-00005 TABLE 5 Components Amount   Product of previous step  20 μL   2X PCR reaction enzyme  25 μL Nested primer pool 2.5 μL Second universal primer 2.5 μL First tag primer 2.5 μL Total  50 μL #The nested primer pool is illustrated in Table 6.

TABLE-US-00006 TABLE 6 Nested primer pool Primer Sequence Nested primer 01 ACATGGCTACGATCCGACTTTCAGTGTTACTT ACCTGTCTTGTC (SEQ ID NO: 14) Nested primer 02 ACATGGCTACGATCCGACTTTCAGGATGGTGG ATGTGGG (SEQ ID NO: 15) Nested primer 03 ACATGGCTACGATCCGACTTGCTGTATCGTCA AGGCACTC (SEQ ID NO: 16) Nested primer 04 ACATGGCTACGATCCGACTTACCCCAATGCAG CGAACAA (SEQ ID NO: 17) Nested primer 05 ACATGGCTACGATCCGACTTAGCTCTCTTGAG GATCTTGAAGG (SEQ ID NO: 18) Nested primer 06 ACATGGCTACGATCCGACTTCTGCCTCACCTC CACCGT (SEQ ID NO: 19) Nested primer 07 ACATGGCTACGATCCGACTTAACACCGCAGCA TGTCAA (SEQ ID NO: 20) Nested primer 08 ACATGGCTACGATCCGACTTTGTGATTTTGGT CTAGCCAGAG (SEQ ID NO: 21) Nested primer 09 ACATGGCTACGATCCGACTTGATGATGGGCTC CCGGAA (SEQ ID NO: 22) Nested primer 10 ACATGGCTACGATCCGACTTCGTCTCCTCCGA CCACTGT (SEQ ID NO: 23) Nested primer 11 ACATGGCTACGATCCGACTTGATCCAGACAAC TGTTCAAACTG (SEQ ID NO: 24) Nested primer 12 ACATGGCTACGATCCGACTTGCAATTTCTACA CGAGATCCTCT (SEQ ID NO: 25) Nested primer 13 ACATGGCTACGATCCGACTTGCAAGAGGCTTT GGAGTATTTCATG (SEQ ID NO: 26)

[0062] The nested primer pool was formed by mixing 10 μM of the above primers at an equimolar ratio.

[0063] First tag primer: TGTGAGCCAAGGAGTNNNNNNNNNN.sup.#TTGTCTTCCTAAGACCGCTTGGCCTCCG ACTT (SEQ ID NO: 40), # where the N is the tag sequence, which is random base.

[0064] Second universal primer: /5Phos/#GAACGACATGGCTACGATCCGACTT (SEQ ID NO: 41), where the 5′-end of the primer is phosphorylated and used for the circularization of the MGI platform.

[0065] The first round of PCR amplification was performed according to the procedure in Table 7 below.

TABLE-US-00007 TABLE 7 Temperature Duration The number of cycles 95° C. 2 min  1 cycle 95° C. 10 s 24 cycles 62° C. 2 min 72° C. 30 s 72° C. 5 min  1 cycle

[0066] 80 μL of XP magnetic beads were added to the obtained PCR product for purification (Agencourt AMPure XP magnetic beads from Beckman, Cat No. A63881), and the obtained product was dissolved in 20 μL of TE solution.

[0067] 3. Library quality inspection

[0068] The library was tested, the band range was between 150 bp and 200 bp, and the results are listed in FIG. 8.

[0069] 4. Sequencing

[0070] All the obtained products were standardized and mixed in equal amounts, and the mixed library was subjected to parallel sequencing, with a sequencing platform MGISEQ-2000 and a sequencing type PE100.

[0071] 5. Data analysis

[0072] The analysis steps include basic steps such as filtering of the adapter primer sequences, alignment and so on. The basic information obtained is listed in Table 8. Then, GATK was used to detect mutations at the targeted site (Table 9).

TABLE-US-00008 TABLE 8 Statistics of sequencing data Mapping Capture Average Uniformity No. Raw data rate rate depth 0.2X Sample 1  8349037 99.85% 99.72% 1277933 100% Sample 2 11265885 99.85% 99.68% 1711470 100% Sample 3 10184135 99.88% 99.73% 1542768 100% Sample 4 15748586 99.89% 99.75% 2389774 100%

TABLE-US-00009 TABLE 9 Detection of mutation sites Theoretical Actual Actual Actual Actual Mutation detection detection detection detection detection sites value value 1 value 2 value 3 value 4 E545K  9.0%  9.7%  9.3%  9.6%  8.6% H1047R 17.5% 18.7% 18.4% 17.2% 15.8% D816V 10.0%  9.2% 11.0%  9.2% 10.2% G719S 24.5% 26.7% 23.5% 24.5% 26.5% T790M  1.0%  0.9%  1.0%  1.0%  1.0% L858R  3.0%  3.1%  2.9%  3.3%  3.1% V600E 10.5%  9.6% 11.2%  9.8% 10.3% G13D 15.0% 14.7% 14.7% 16.5% 13.8% G12D  6.0%  6.5%  6.3%  6.4%  6.2%

[0073] It can be seen from FIG. 8 that, the products obtained by using the nested multiplex PCR do not contain the primer dimers and the non-specific products. Table 8 indicates that both the mapping rate and the capture rate in the sequencing data can reach 99%, the uniformity of 0.2× average depth can reach 100%, and the depth of each amplicon is within 7 times (FIG. 7), indicating an excellent amplification performance. The mutation detection performed on the targeted sites indicates that the mutation frequencies actually detected in all samples are close to the detected mutation frequency of the standard, and the actual values are approximately equal to 1±0.1 times the theoretical value (Table 9).

[0074] The above applies specific examples to explain the present disclosure, which are only used to help understanding the present disclosure, but not mean to limit the present disclosure. Those skilled in the art can also make several simple deductions, modifications, or substitutions based on the concept of the present disclosure.